沙利度胺联合地塞米松治疗老年多发性骨髓瘤的疗效分析及不良反应

吴宁宁; 吴宁宁

doi:10.3969/j.issn.1006-0111.2012.06.014

[1]

沙信山,李永辉,张桂芳,等.小剂量沙利度胺联合长春地辛、吡喃阿霉素和地塞米松方案治疗老年多发性骨髓瘤[J].中华实用诊断与治疗杂志,2009,23(3):303.

[2]

中国多发性骨髓瘤工作组.中国多发性骨髓瘤诊治指南[J].中华内科杂志,2008,47(10):869.

[3]

Facon T, Mary JY, Pegourie B, et al. Dexamethasone-based regi-mens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy[J]. Blood,2006,107(4):1292.

[4]

Fujita J,Mestre JR,Zeldis JB,et al.Thalidomide and its analogues inhibit lipop1ysaccharide mediated linduction of cyclooxygenase 2[J].Clin Cancer Res,2001,7(11):3349.

[5]

顾惠慈.三氧化二砷联合化疗治疗难治复发多发骨髓瘤的临床疗效分析[J].实用诊断与治疗杂志,2006,20(12):918.

[6]

张之南.血液病诊断及疗效标准[M].第2版,北京:科学出版社,1998:73.